Dr. Justin Michael Paolino is a pharmacist who is specialized in Nuclear in Boston, Massachusetts. Patients can reach him at 75 Francis St, Boston or contact him on 617-732-7171. Active license number of Dr. Justin Michael Paolino is 26791 for Nuclear in Massachusetts. Dr. Justin Michael Paolino is a licensed pharmacist who has demonstrated specialized knowledge and skill in procurement, compounding, quality control testing, dispensing, distribution, and monitoring of radiopharmaceuticals.
Complete Profile:
Dr. Justin Michael Paolino speciality, credentials, practice address, contact phone number and fax are as below. Patients can call on the below given phone number for enquiries.
Name:
Dr. Justin Michael Paolino
Specialization:
Nuclear
Credentials:
PHARMD, BCNP
Gender:
Male
Location:
75 Francis St, Boston, Massachusetts, 02115-6110
Phone:
617-732-7171
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details of Dr. Justin Michael Paolino are as mentioned below.
NPI Number:
1073720728
NPI Enumeration Date:
16 May, 2007
NPI Last Update On:
27 Jan, 2009
Medical Licenses:
Pharmacists can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Dr. Justin Michael Paolino are as mentioned below.
Specialization
License Number
State
Status
Nuclear
26791
Massachusetts
Primary
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
75 Francis St, Boston, Massachusetts
Zip:
02115-6110
Phone Number:
--
Fax Number:
--
Patients can reach Dr. Justin Michael Paolino at 75 Francis St, Boston, Massachusetts or can call on phone at 617-732-7171.
Comments/ Reviews:
*Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 11 November, 2024.